User profiles for Lina Souan

Lina Souan

Professor of Immunology, King Hussein Cancer Center
Verified email at khcc.jo
Cited by 725

Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo

AB Dietz, L Souan, GJ Knutson, PA Bulur, MR Litzow… - Blood, 2004 - ashpublications.org
Imatinib mesylate (STI571, imatinib) inhibited DNA synthesis in primary human T cells
stimulated with allogeneic mature dendritic cells or phytohemagglutinin (PHA) but did not induce …

Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan

L Souan, M Siag, H Al-Salahat, T Al-Atrash… - BMC Infectious …, 2021 - Springer
Background Hepatitis B and C infections and transmission are a serious challenge to all
healthcare systems. We studied seroprevalence rates of Transfusion Transmitted Diseases (TTD…

Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients

L Souan, H Abdel-Razeq, M Al Zughbieh, S Al Badr… - Viruses, 2023 - mdpi.com
Objective: The kinetics of immune responses to various SARS-CoV-2 vaccines in cancer
patients were investigated. Methods: In total, 57 cancer patients who received BNT162b2-RNA …

Modulation of proteinase‐K resistant prion protein by prion peptide immunization

L Souan, Y Tal, Y Felling, IR Cohen… - European journal of …, 2001 - Wiley Online Library
Prion diseases are caused by conformational alterations in the prion protein (PrP). The immune
system has been assumed to be non‐responsive to the self‐prion protein, therefore, PrP …

[HTML][HTML] Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic

MA Sughayer, A Mansour, A Al Nuirat, L Souan… - International Journal of …, 2021 - Elsevier
Background Seroprevalence studies of SARS-CoV-2 antibodies are useful in assessing the
epidemiological status in the community, and the degree of spread. Objective To study the …

COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study

L Souan, H Abdel-Razeq, S Nashwan, S Al Badr… - Vaccines, 2023 - mdpi.com
Background: The effective development of COVID-19 vaccination has mitigated its harm. Using
two laboratory methods, we investigated the efficacy of the BNT162b2 mRNA and BBIBP-…

The Effect of Dexamethasone Treatment on COVID-19 Prognosis in Cancer Patients

L Souan, Z Al-Khairy, MA Al-Binni, A Battah… - Vaccines, 2022 - mdpi.com
Background: Dexamethasone is used to treat cancer, relieve chemotherapy-induced nausea
and vomiting, enhance cancer patients’ appetites, and treat COVID-19 patients. There is …

An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations

L Souan, MA Sughayer, M Abu Alhowr… - Frontiers in public …, 2022 - frontiersin.org
Background: Aside from the pandemic's negative health effects, the world was confronted
with public confusion since proper communication and favorable decisions became an …

Seroprevalence rates of transfusion-transmitted infections among blood donors in Jordan

L Souan, F Tout, M Siag, MA Sughayer - The Journal of Infection in …, 2016 - jidc.org
Introduction: Statistics on the prevalence of donor screening for hepatitis B surface antigen (HBsAg)
and anti-hepatitis C virus (anti-HCV) in Jordan are outdated. There are no studies on …

QuantiFERON‐CMV and monitor predict cytomegalovirus, mortality, and graft‐versus‐host disease in transplant recipients

L Souan, HA Jazar, S Nashwan… - Journal of Medical …, 2023 - Wiley Online Library
Lina Souan and Maher A. Sughayer were responsible for funding acquisition, investigation,
project administration, and resources. Lina Souan was responsible for supervision, validation…